Rainbow Childrens Medicare Share Price
Sector: Healthcare Facilities
1501.90 -10.10 (-0.67%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1495.20
Today’s High
1525.95
52 Week Low
1079.25
52 Week High
1708.50
1503.20 -9.00 (-0.60%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1496.70
Today’s High
1512.20
52 Week Low
1079.10
52 Week High
1709.60
Key Metrics
- Market Cap (In Cr) 15252.05
- Beta -
- Div. Yield (%) 0.2
- P/B 12.12
- TTM P/E 63.98
- Sector P/E 22.83
- Open Price 1525.95
- Prev Close 1512
Rainbow Childrens Medicare Analysis
Price Analysis
-
1 Week1.59%
-
3 Months2.43%
-
6 Month3.52%
-
YTD0.24%
-
1 Year14.56%
Risk Meter
- 38% Low risk
- 38% Moderate risk
- 38% Balanced Risk
- 38% High risk
- 38% Extreme risk
Rainbow Childrens Medicare News
Hospital stocks rise after Health Minister reports 3 cases of HMPV in India
1 min read . 06 Jan 2025Rainbow Childrens Medicare Q3 FY24 Results Live : profit rise by 7.27% YOY
1 min read . 27 Jan 2024Rainbow Children's Medicare IPO: GMP, share allotment, listing date details
1 min read . 02 May 2022Rainbow Children's Medicare IPO: GMP, subscription status on last day of issue
1 min read . 29 Apr 2022Rainbow Childrens Medicare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1296.9
- Selling/ General/ Admin Expenses Total
- 672.31
- Depreciation/ Amortization
- 112.08
- Other Operating Expenses Total
- 0.73
- Total Operating Expense
- 977.01
- Operating Income
- 319.89
- Net Income Before Taxes
- 294.81
- Net Income
- 217
- Diluted Normalized EPS
- 21.32
- Period
- 2024
- Total Assets
- 2170.4
- Total Liabilities
- 911.47
- Total Equity
- 1258.93
- Tangible Book Valueper Share Common Eq
- 123.03
- Period
- 2024
- Cashfrom Operating Activities
- 321.4
- Cashfrom Investing Activities
- -226.47
- Cashfrom Financing Activities
- -101.78
- Net Changein Cash
- -6.85
- Period
- 2023
- Total Revenue
- 1173.57
- Selling/ General/ Admin Expenses Total
- 593.42
- Depreciation/ Amortization
- 90.27
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 867.25
- Operating Income
- 306.32
- Net Income Before Taxes
- 281.78
- Net Income
- 210.83
- Diluted Normalized EPS
- 21.11
- Period
- 2023
- Total Assets
- 1770.72
- Total Liabilities
- 710.81
- Total Equity
- 1059.91
- Tangible Book Valueper Share Common Eq
- 103.9
- Period
- 2023
- Cashfrom Operating Activities
- 328.78
- Cashfrom Investing Activities
- -465.2
- Cashfrom Financing Activities
- 143.41
- Net Changein Cash
- 6.99
- Period
- 2022
- Total Revenue
- 973.76
- Selling/ General/ Admin Expenses Total
- 450.98
- Depreciation/ Amortization
- 83.26
- Other Operating Expenses Total
- 0.8
- Total Operating Expense
- 746.57
- Operating Income
- 227.19
- Net Income Before Taxes
- 187.35
- Net Income
- 138.27
- Diluted Normalized EPS
- 14.45
- Period
- 2022
- Total Assets
- 1295.75
- Total Liabilities
- 692.94
- Total Equity
- 602.8
- Tangible Book Valueper Share Common Eq
- 63.5
- Period
- 2022
- Cashfrom Operating Activities
- 223.73
- Cashfrom Investing Activities
- -175.35
- Cashfrom Financing Activities
- -44.06
- Net Changein Cash
- 4.32
- Period
- 2021
- Total Revenue
- 650.05
- Selling/ General/ Admin Expenses Total
- 369.22
- Depreciation/ Amortization
- 73.34
- Other Operating Expenses Total
- 0.56
- Total Operating Expense
- 560.22
- Operating Income
- 89.83
- Net Income Before Taxes
- 55.7
- Net Income
- 40.02
- Diluted Normalized EPS
- 4.35
- Period
- 2021
- Total Assets
- 1081.27
- Total Liabilities
- 634.9
- Total Equity
- 446.36
- Tangible Book Valueper Share Common Eq
- 48.11
- Period
- 2021
- Cashfrom Operating Activities
- 142.71
- Cashfrom Investing Activities
- -82.88
- Cashfrom Financing Activities
- -60.87
- Net Changein Cash
- -1.04
- Period
- 2020
- Total Revenue
- 719.39
- Selling/ General/ Admin Expenses Total
- 401.36
- Depreciation/ Amortization
- 69.41
- Other Operating Expenses Total
- 0.82
- Total Operating Expense
- 591.77
- Operating Income
- 127.63
- Net Income Before Taxes
- 93.36
- Net Income
- 55.73
- Diluted Normalized EPS
- 6.06
- Period
- 2020
- Total Assets
- 1019.24
- Total Liabilities
- 613.83
- Total Equity
- 405.4
- Tangible Book Valueper Share Common Eq
- 43.57
- Period
- 2020
- Cashfrom Operating Activities
- 170.41
- Cashfrom Investing Activities
- -117.03
- Cashfrom Financing Activities
- -51.81
- Net Changein Cash
- 1.56
- Period
- 2019
- Total Revenue
- 542.79
- Selling/ General/ Admin Expenses Total
- 299.85
- Depreciation/ Amortization
- 60.32
- Other Operating Expenses Total
- 0.55
- Total Operating Expense
- 453.28
- Operating Income
- 89.51
- Net Income Before Taxes
- 57.53
- Net Income
- 44.59
- Diluted Normalized EPS
- 4.85
- Period
- 2019
- Total Assets
- 926.4
- Total Liabilities
- 554.25
- Total Equity
- 372.15
- Tangible Book Valueper Share Common Eq
- 39.81
- Period
- 2019
- Cashfrom Operating Activities
- 127.24
- Cashfrom Investing Activities
- -116.89
- Cashfrom Financing Activities
- -8.69
- Net Changein Cash
- 1.66
- Period
- 2024-12-31
- Total Revenue
- 398.08
- Selling/ General/ Admin Expenses Total
- 143.68
- Depreciation/ Amortization
- 35.23
- Other Operating Expenses Total
- 66.32
- Total Operating Expense
- 298.96
- Operating Income
- 99.12
- Net Income Before Taxes
- 94.33
- Net Income
- 68.69
- Diluted Normalized EPS
- 6.76
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 417.46
- Selling/ General/ Admin Expenses Total
- 53.75
- Depreciation/ Amortization
- 34.9
- Other Operating Expenses Total
- 164.96
- Total Operating Expense
- 305.28
- Operating Income
- 112.18
- Net Income Before Taxes
- 105.35
- Net Income
- 78.87
- Diluted Normalized EPS
- 7.77
- Period
- 2024-09-30
- Total Assets
- 2261.93
- Total Liabilities
- 918.5
- Total Equity
- 1343.43
- Tangible Book Valueper Share Common Eq
- 131.21
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 192.81
- Cashfrom Investing Activities
- -114.26
- Cashfrom Financing Activities
- -73.33
- Net Changein Cash
- 5.22
- Period
- 2024-06-30
- Total Revenue
- 330.22
- Selling/ General/ Admin Expenses Total
- 49
- Depreciation/ Amortization
- 34.14
- Other Operating Expenses Total
- 145.02
- Total Operating Expense
- 270.64
- Operating Income
- 59.58
- Net Income Before Taxes
- 53.35
- Net Income
- 39.53
- Diluted Normalized EPS
- 3.89
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 341.1
- Selling/ General/ Admin Expenses Total
- 124.83
- Depreciation/ Amortization
- 32.3
- Other Operating Expenses Total
- 65.93
- Total Operating Expense
- 264.99
- Operating Income
- 76.11
- Net Income Before Taxes
- 69.17
- Net Income
- 50.97
- Diluted Normalized EPS
- 4.97
- Period
- 2024-03-31
- Total Assets
- 2170.4
- Total Liabilities
- 911.47
- Total Equity
- 1258.93
- Tangible Book Valueper Share Common Eq
- 123.03
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 321.4
- Cashfrom Investing Activities
- -226.47
- Cashfrom Financing Activities
- -101.78
- Net Changein Cash
- -6.85
- Period
- 2023-12-31
- Total Revenue
- 335.96
- Selling/ General/ Admin Expenses Total
- 120.64
- Depreciation/ Amortization
- 27.66
- Other Operating Expenses Total
- 54.55
- Total Operating Expense
- 245.54
- Operating Income
- 90.42
- Net Income Before Taxes
- 84.77
- Net Income
- 62.13
- Diluted Normalized EPS
- 6.12
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 332.68
- Selling/ General/ Admin Expenses Total
- 120.22
- Depreciation/ Amortization
- 26.8
- Other Operating Expenses Total
- 52.65
- Total Operating Expense
- 241.91
- Operating Income
- 90.77
- Net Income Before Taxes
- 85.25
- Net Income
- 62.91
- Diluted Normalized EPS
- 6.2
- Period
- 2023-09-30
- Total Assets
- 1897.54
- Total Liabilities
- 758.12
- Total Equity
- 1139.42
- Tangible Book Valueper Share Common Eq
- 111.71
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 151.66
- Cashfrom Investing Activities
- -91.87
- Cashfrom Financing Activities
- -63.85
- Net Changein Cash
- -4.06
- Period
- 2023-06-30
- Total Revenue
- 287.17
- Selling/ General/ Admin Expenses Total
- 113.44
- Depreciation/ Amortization
- 25.33
- Other Operating Expenses Total
- 47.63
- Total Operating Expense
- 224.79
- Operating Income
- 62.38
- Net Income Before Taxes
- 55.62
- Net Income
- 41
- Diluted Normalized EPS
- 4.04
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 316.97
- Selling/ General/ Admin Expenses Total
- 112.52
- Depreciation/ Amortization
- 22.73
- Other Operating Expenses Total
- 63.71
- Total Operating Expense
- 241.69
- Operating Income
- 75.28
- Net Income Before Taxes
- 70.1
- Net Income
- 53.6
- Diluted Normalized EPS
- 5.31
- Period
- 2023-03-31
- Total Assets
- 1770.96
- Total Liabilities
- 711.05
- Total Equity
- 1059.91
- Tangible Book Valueper Share Common Eq
- 103.9
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 327.23
- Cashfrom Investing Activities
- -465.2
- Cashfrom Financing Activities
- 143.41
- Net Changein Cash
- 5.43
- Period
- 2022-12-31
- Total Revenue
- 306.4
- Selling/ General/ Admin Expenses Total
- 112.1
- Depreciation/ Amortization
- 23.18
- Other Operating Expenses Total
- 47.31
- Total Operating Expense
- 222.83
- Operating Income
- 83.58
- Net Income Before Taxes
- 78.32
- Net Income
- 57.92
- Diluted Normalized EPS
- 5.74
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Rainbow Childrens Medicare Technical
Moving Average
SMA
- 5 Day1516.52
- 10 Day1450.75
- 20 Day1365.4
- 50 Day1355.76
- 100 Day1465.74
- 300 Day1388.41
Rainbow Childrens Medicare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Aster Dm Healthcare
- 499.6
- -0.75
- -0.15
- 534
- 312.25
- 24955.67
- Dr. Lal Pathlabs
- 2706
- -65.1
- -2.35
- 3645
- 2168.8
- 22619.92
- Rainbow Childrens Medicare
- 1501.9
- -10.1
- -0.67
- 1708.5
- 1079.25
- 15252.05
- Vijaya Diagnostic Centre
- 1045
- 56.85
- 5.75
- 1276.75
- 649
- 10725.49
- Metropolis Healthcare
- 1660.35
- -6.65
- -0.4
- 2306.85
- 1383.7
- 8514.46
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Aster Dm Healthcare
- 203.23
- 5.45
- 6.24
- 4.26
- Dr. Lal Pathlabs
- 63.12
- 12.21
- 21.32
- 15.99
- Rainbow Childrens Medicare
- 70.52
- 12.12
- 19.88
- 13.8
- Vijaya Diagnostic Centre
- 89.73
- 16.21
- 22.14
- 21.2
- Metropolis Healthcare
- 66.85
- 7.77
- 20.59
- 14.66
Rainbow Childrens Medicare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 09-Feb-25
- Quarterly Results & Others
- 27-Oct-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 19-May-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 30-Oct-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 14-May-23
- Audited Results & Final Dividend
- 09-Feb-23
- Quarterly Results
- 03-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 04-Apr-25
- 03-Mar-25
- POM
- 30-Jul-24
- 21-May-24
- AGM
- 19-Mar-24
- 15-Feb-24
- POM
- 27-Dec-23
- 23-Nov-23
- POM
- 29-Jun-23
- 14-May-23
- AGM
- 09-May-23
- 06-Apr-23
- POM
- 15-Sept-22
- 08-Aug-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 21-May-24
- 23-Jul-24
- 23-Jul-24
- 3
- 15-May-23
- 22-Jun-23
- 22-Jun-23
- 3


